Redefining Panfacial Rejuvenation: A Paradigm Shift Employing the Volumetric Structural Rejuvenation Approach
 
Release Date: April 29, 2019
Last Reviewed: April 24, 2019
Expiration Date: April 29, 2020
Time to Complete Activity: 0.75 hours
 
Faculty/Steering Committee
Neil S. Sadick, MD, FAAD, FAACS, FACP, FACPh (Co-chair)
Clinical Professor of Dermatology
Department of Dermatology
Weill Cornell Medical College
Medical Director
Sadick Research Group
New York, NY
 
Steering Committee
Sabrina G. Fabi, MD, FAAD, FAACS
Volunteer Assistant Clinical Professor
Department of Medicine/Dermatology
University of California, San Diego
Goldman Butterwick Fitzpatrick Groff and Fabi Cosmetic Laser Dermatology
San Diego, CA

This activity is provided by Paradigm Medical Communications, LLC.  
 
Target Audience
This activity has been designed to address the educational needs of dermatologists, dermatologic surgeons, plastic surgeons, facial plastic surgeons, oculoplastic surgeons, ophthalmologists, otolaryngologists, nurse practitioners, and PAs. It may also be of benefit to other physicians, nurses, and healthcare providers who are involved in the field of aesthetic medicine.
 
Statement of Need
Optimal use of injectable agents is based on comprehensive knowledge of the anatomic changes seen with facial aging, the products to be used, and the latest techniques. The Volumetric Structural Rejuvenation approach to panfacial rejuvenation utilizes new generation soft tissue fillers and a bimodal (2-step), trivector (3 injection site) technique based on sequential repletion of the deep fat pads with depot injections, followed by more superficial injections to correct localized areas of volume loss, customize contours, and create facial symmetry. Neuromodulators and other modalities are then selectively used as part of a refined, individualized treatment plan agreed upon by both physician and patient. This activity has been designed to educate aesthetic clinicians on how to effectively and safely select and use available soft tissue fillers and neuromodulators to facilitate natural, harmonious, panfacial rejuvenation.
 
Learning Objectives
Upon proper completion of this activity, participants should be better able to:
  • Perform comprehensive assessment of anatomic changes throughout the aging face to inform creation of a comprehensive plan of care for optimal facial volumization and rejuvenation.
  • Select appropriate treatment for aesthetic rejuvenation throughout the face based on the indications, efficacy, and potential adverse events of available soft tissue fillers and neuromodulators.
  • Incorporate the latest strategies and techniques for optimal individualized facial volumization and rejuvenation with soft tissue fillers and neuromodulators.

Physician Accreditation Statement
Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
 
Physician Credit Designation Statement
Paradigm Medical Communications, LLC designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PA Continuing Education
PAs may claim a maximum of 0.75 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
 
Nurse Practitioner Continuing Education
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
 
Disclosure of Commercial Support
This activity is supported by an educational grant from Allergan, Inc.
 
Instructions for Participation
To receive a CME certificate of participation, you should:
  • Follow instructions to register or log in with your professional information and complete the pre-activity assessment
  • View the online activity in its entirety.
  • Complete and submit the online posttest and evaluation.
A certificate of participation will be available for download/printing immediately following your successful completion of the posttest and evaluation.

For questions regarding CME credit, contact the Paradigm CME Department at (845) 398-5949.
 
There is no fee required for participation in this activity.

Hardware/Software Requirements
This certified CME activity is designed using HTML5 video. As you navigate the video using the supplied controls, the slides will sync to the speaker.
 
Supported Browsers:
For Desktops (Windows/Mac)
Internet Explorer 9 or higher, Firefox 28 or higher, Safari 5.1 or higher, Google Chrome 31 or higher, Opera 21 or higher
 
For Tablets (iPad/Android/Surface)
iOS Safari 4 or higher, Android 2.3 or higher, IE Mobile 10 or higher
 
Technical Support: If you have any technical problems or playback issues email us at contactus@paradigmmc.com.
 
Disclosures
In accordance with Accreditation Council for Continuing Medical Education requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below.
 
Faculty/Steering Committee
Neil S. Sadick, MD, FAAD, FAACS, FACP, FACPh
Advisory Board: Allergan, Inc
Consultant: Allergan, Inc; Almirall, S.A.; Galderma Laboratories, L.P.; Venus Concept
Stockholder: Vascular Insights, LLC
 
Steering Committee
Sabrina G. Fabi, MD, FAAD, FAACS
Consultant: Alastin Skincare, Inc; Allergan, Inc.; Colorscience, Inc.; Endo Pharmaceuticals Inc.; EVOLUS; Galderma Laboratories, L.P.; Merz North America, Inc.; Revance Therapeutics, Inc; ThermiGen, LLC; Valeant Pharmaceuticals International, Inc
Speakers’ Bureau: Alastin Skincare, Inc; Allergan, Inc.; EVOLUS; Galderma Laboratories, L.P.; Merz North America, Inc.; ThermiGen, LLC; Valeant Pharmaceuticals International, Inc
Grant/Research Support: Alastin Skincare, Inc; Allergan, Inc.; Ampersand Aesthetics; Bayer HealthCare; Colorscience, Inc.; Endo Pharmaceuticals Inc.; Galderma Laboratories, L.P.; Merz North America, Inc.; Revance Therapeutics, Inc
Stockholder: Allergan, Inc.; Revance Therapeutics, Inc
 
Paradigm Medical Communications, LLC staff members have no financial relationships to disclose.

Independent peer reviewer has no financial relationships to disclose.
 
Resolution of Conflict of Interest
Paradigm Medical Communications, LLC has implemented a system to resolve conflicts of interest for each CME activity to help ensure content is objective, fair and balanced, independent, and aligned with the public interest. Conflicts, if any, are resolved through one or more processes. All CME content in this activity was independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the ACCME’s Standards for Commercial Support of Continuing Medical Education.
 
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.
 
Disclaimer
This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

If included, signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified.
 
As an ACCME-accredited provider, Paradigm Medical Communications, LLC activities must include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. In this activity, the trade names for neuromodulators and soft tissue fillers may be used for clarity. The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC.
 
Terms of Use and Privacy Policy
Disclaimer
The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. Any views or opinions presented are solely those of the Faculty, and do not necessarily represent those of Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC. Paradigm Medical Communications, LLC accepts no liability for the content referenced in this activity.
 
Privacy policy
Paradigm Medical Communications, LLC is committed to protecting the privacy of those who participate in the activities located at www.paradigmmc.com (herein referred to as “website"). The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.
 
Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.
 
Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC to continuously improve the learning experience.
 
Paradigm Medical Communications, LLC does not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC staff members review individual test results to the extent necessary to record and track participants’ credits.
 
Contact Us
If you have any questions or comments, please email us at contactus@paradigmmc.com.
 
© 2019 Paradigm Medical Communications, LLC except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.